These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 17011846)

  • 1. Topical interferon alfa-2b for the treatment of recalcitrant ocular surface squamous neoplasia.
    Holcombe DJ; Lee GA
    Am J Ophthalmol; 2006 Oct; 142(4):568-71. PubMed ID: 17011846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of recurrent corneal and conjunctival intraepithelial neoplasia with topical interferon alfa 2b.
    Boehm MD; Huang AJ
    Ophthalmology; 2004 Sep; 111(9):1755-61. PubMed ID: 15350333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topical interferon alfa-2b for management of ocular surface squamous neoplasia in 23 cases: outcomes based on American Joint Committee on Cancer classification.
    Shah SU; Kaliki S; Kim HJ; Lally SE; Shields JA; Shields CL
    Arch Ophthalmol; 2012 Feb; 130(2):159-64. PubMed ID: 22332208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perilesional and topical interferon alfa-2b for conjunctival and corneal neoplasia.
    Vann RR; Karp CL
    Ophthalmology; 1999 Jan; 106(1):91-7. PubMed ID: 9917787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of conjunctival and corneal epithelial neoplasia with retinoic acid and topical interferon alfa-2b: long-term follow-up.
    Krilis M; Tsang H; Coroneo M
    Ophthalmology; 2012 Oct; 119(10):1969-73. PubMed ID: 22704834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term follow-up of conjunctival and corneal intraepithelial neoplasia treated with topical interferon alfa-2b.
    Schechter BA; Koreishi AF; Karp CL; Feuer W
    Ophthalmology; 2008 Aug; 115(8):1291-6, 1296.e1. PubMed ID: 18187195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topical Interferon α-2b as a Single Therapy for Primary Ocular Surface Squamous Neoplasia.
    Kusumesh R; Ambastha A; Sinha B; Kumar R
    Asia Pac J Ophthalmol (Phila); 2015; 4(5):279-82. PubMed ID: 26176194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical interferon or surgical excision for the management of primary ocular surface squamous neoplasia.
    Sturges A; Butt AL; Lai JE; Chodosh J
    Ophthalmology; 2008 Aug; 115(8):1297-302, 1302.e1. PubMed ID: 18294690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for ocular surface squamous neoplasia recurrence after treatment with topical mitomycin C and interferon alpha-2b.
    Besley J; Pappalardo J; Lee GA; Hirst LW; Vincent SJ
    Am J Ophthalmol; 2014 Feb; 157(2):287-293.e2. PubMed ID: 24184223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surgical versus medical treatment of ocular surface squamous neoplasia: a comparison of recurrences and complications.
    Nanji AA; Moon CS; Galor A; Sein J; Oellers P; Karp CL
    Ophthalmology; 2014 May; 121(5):994-1000. PubMed ID: 24411578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of Topical 5-Fluorouracil and Interferon Alfa-2b as Primary Treatment Modalities for Ocular Surface Squamous Neoplasia.
    Venkateswaran N; Mercado C; Galor A; Karp CL
    Am J Ophthalmol; 2019 Mar; 199():216-222. PubMed ID: 30471241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of conjunctival and corneal intraepithelial neoplasia with topical interferon alpha-2b.
    Karp CL; Moore JK; Rosa RH
    Ophthalmology; 2001 Jun; 108(6):1093-8. PubMed ID: 11382635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topical chemotherapy for giant ocular surface squamous neoplasia of the conjunctiva and cornea: Is surgery necessary?
    Chaugule SS; Park J; Finger PT
    Indian J Ophthalmol; 2018 Jan; 66(1):55-60. PubMed ID: 29283124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interferon alpha 2b treatment for residual ocular surface squamous neoplasia unresponsive to excision, cryotherapy and mitomycin-C.
    Nemet AY; Sharma V; Benger R
    Clin Exp Ophthalmol; 2006; 34(4):375-7. PubMed ID: 16764660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in in vivo confocal microscopic findings of ocular surface squamous neoplasia during treatment with topical interferon alfa-2b.
    Zarei-Ghanavati M; Mousavi E; Nabavi A; Latifi G; Mehrjardi HZ; Mohebbi M; Ghassemi H; Mirzaie F; Zare MA
    Ocul Surf; 2018 Apr; 16(2):235-241. PubMed ID: 29306088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topical interferon alpha 2b eye-drops for treatment of ocular surface squamous neoplasia: a dose comparison study.
    Galor A; Karp CL; Chhabra S; Barnes S; Alfonso EC
    Br J Ophthalmol; 2010 May; 94(5):551-4. PubMed ID: 19493859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Giant ocular surface squamous neoplasia managed with interferon alpha-2b as immunotherapy or immunoreduction.
    Kim HJ; Shields CL; Shah SU; Kaliki S; Lally SE
    Ophthalmology; 2012 May; 119(5):938-44. PubMed ID: 22361315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitomycin C or interferon as adjuvant therapy to surgery for ocular surface squamous neoplasia: comparative study.
    Blasi MA; Maceroni M; Sammarco MG; Pagliara MM
    Eur J Ophthalmol; 2018 Mar; 28(2):204-209. PubMed ID: 28967069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized controlled trial of topical mitomycin C for ocular surface squamous neoplasia: early resolution.
    Hirst LW
    Ophthalmology; 2007 May; 114(5):976-82. PubMed ID: 17241666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regression of presumed primary conjunctival and corneal intraepithelial neoplasia with topical interferon alpha-2b.
    Schechter BA; Schrier A; Nagler RS; Smith EF; Velasquez GE
    Cornea; 2002 Jan; 21(1):6-11. PubMed ID: 11805499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.